QR-Code

Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations

Abstract In Peru, 29 292 people were diagnosed with tuberculosis in 2022. Although tuberculosis treatments are effective, 3.4%–13% are associated with significant adverse drug reactions, with drug‐induced liver injury (DILI) considered the most predominant. Among the first‐line antituberculosis drug...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Luis Jaramillo‐Valverde, Kelly S. Levano, David D. Tarazona, Silvia Capristano, Cesar Sanchez, Julio A. Poterico, Eduardo Tarazona‐Santos, Heinner Guio
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley 2024-06-01
Schriftenreihe:Pharmacology Research & Perspectives
Schlagworte:
genotype
native and mestizo population
Pharmacogenetic
tuberculosis
Online-Zugang:https://doi.org/10.1002/prp2.1179
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge